Breaking News

A call to action on Covid drug licensing; enrollment lags in Cassava Alzheimer's studies

 

Pharmalot Ed Silverman

STAT+: Colombian government faces calls to issue compulsory license for Pfizer's Covid-19 pill

By Ed Silverman

Pfizer

The longer-term goal is to make it possible for Colombia to develop its own production capacity for both vaccines and treatments.

Read More

STAT+: Douglas Melton, noted stem cell researcher, leaves Harvard for Vertex to create diabetes treatments

By Matthew Herper

Stephanie Mitchell/Harvard Staff

Melton, who uses stem cells to create beta cells, said he wanted to work somewhere where that kind of work was being put into practice.

Read More

STAT+: Troubles mount for Cassava Sciences, as patient enrollment lags for Alzheimer's drug studies

By Adam Feuerstein

Screen capture via Cassava Sciences

It's a sign that investigations over the credibility of Cassava Sciences' drug simufilam have made physicians and patients wary.

Read More

'All the shrapnel that's in my back': Defiant Robert Redfield blasts former CDC directors for criticism during Covid-19

By Lev Facher

Samuel Corum/Getty Images

Trump's CDC director teed off on other former agency leaders, arguing their criticism during Covid further damaged trust in public health.

Read More

Tuesday, April 5, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments